Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1906 of 6351
-
New bird flu booster shot shows promise in early trial
Vaccine CompletedThis is a Phase 2, randomized, multi-center study in approximately 300 adults who received 2 doses of aH5N1c or placebo in and completed the parent study V89\_18 in the \<65 years of age cohort. The study investigates whether two priming doses of MF59-adjuvanted H5N1 cell culture…
Phase 2 • Sponsor: Seqirus • Aim: Vaccine
Last updated Jun 27, 2026 12:33 UTC
-
New radiation approach aims to tame High-Risk prostate cancer
Disease control Recruiting nowThis is a single-arm phase II prospective trials that is recruiting 100 participants. The study population that is being investigated are patients with localized high-risk or node-positive prostate cancer. Participants will receive external beam radiotherapy as a moderately hypof…
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug aims to stop nosebleeds in rare genetic disorder
Disease control OngoingPart I: The purpose of this Phase 1b proof of concept study, randomised, placebo controlled, double blind, multicentre study is to asssess safety and efficacy of 2 doses of VAD044 in adult HHT patients. Part II: The purpose of this open-label extension following the completion o…
Phase 1/2 • Sponsor: Vaderis Therapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Nature trails may be a new prescription for foot pain
Disease control Recruiting nowModern footwear has been implicated as a contributor to foot pathology and changes in the biomechanics of gait. In addition to footwear, the investigators propose that the lack of terrain variation may directly contribute to the development of common foot pathologies, resulting f…
Sponsor: University of Florida • Aim: Disease control
Last updated Sep 09, 2026 23:00 UTC
-
Can a simple antiviral stop hepatitis b from waking up in lymphoma patients?
Disease control OngoingThis phase 2 trial aims to evaluate the efficacy of entecavir prophylacxis for hepatitis B virus (HBV) reactivation that continues until 6 months after completing CD20 monoclonal antibody therapy in patients with CD20-positive B-cell lymphomas and resolved hepatitis B (negative h…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Eye transplant showdown: which surgery saves sight best?
Disease control OngoingDescemet Endothelial Thickness Comparison Trial (DETECT) I is a multi-center, outcome assessor-masked, placebo-controlled clinical trial randomizing 160 patients in a 2x2 factorial design. The purpose of this study is to determine differences in visual outcomes between two types …
Phase 3 • Sponsor: Stanford University • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New hip replacement device put to the test in 288-Patient trial
Disease control Recruiting nowThe purpose of this study is to determine if the use of the HIT Reverse Hip Replacement System is safe and effective in patients undergoing total hip replacement. We will determine whether it is safe and effective by comparing it to the control devices.
Sponsor: Hip Innovation Technology • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can tailored daily routines fix sleep in older adults?
Symptom relief CompletedThe main objective of the study is to improve subjective sleep quality using a multimodal intervention with an intervention and a control group. The multimodal intervention aims to improve circadian Zeitgeber strength. This will be achieved by optimizing daily light exposure, sle…
Sponsor: Mirjam Münch • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Could sound waves help Alzheimer's drugs work better?
Disease control OngoingThe purpose of this study is to assess the safety and feasibility of administering standard of care monoclonal antibody (mAb) infusion therapy in combination with opening the blood-brain barrier with the Exablate Model 4000 Type 2 device in patients with mild Alzheimer's disease …
Early phase 1 • Sponsor: Ali Rezai • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Scrambler therapy offers hope for young cancer survivors with nerve pain
Symptom relief OngoingTo evaluate the efficacy and safety of Scrambler therapy (ST) for chemotherapy-induced painful peripheral neuropathy (CIPN), and the impact of ST on physical functioning and quality of life (QoL) in adolescents and young adults (AYA) cancer patients. In this proposed study, we w…
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Radiation before Chemo-Immunotherapy shows promise in advanced lung cancer
Disease control CompletedThe study is designed as a non-randomized Phase 2 clinical intervention study. The study will include patients with disseminated Non-Small Cell Lung Carcinoma (NSCLC) which are eligible for first line of systemic treatment with immune checkpoint inhibitors and platinum-based chem…
Phase 2 • Sponsor: University Medical Centre Maribor • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a rheumatoid arthritis drug ease Sjogren's symptoms?
Disease control CompletedThe investigators had observed that baricitinib was effective and safe in active pSS patients in a pilot study. So the investigators plan to conduct a multi-center, prospective, open-label, randomized study to evaluate the efficacy and safety of baricitinib in active pSS patients…
Phase 2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New radiation technique aims to make stem cell transplants safer for sickle cell patients
Disease control OngoingThis phase I trial tests the safety and effectiveness of total marrow and lymphoid irradiation (TMLI) and alemtuzumab as a conditioning regimen in patients with sickle cell disease. Conditioning regimens are treatments used to prepare a patient for stem cell transplantation. A st…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a natural compound help kick the vaping habit?
Disease control CompletedThis placebo-controlled Phase 2 study is being conducted at sites within the United States to evaluate the efficacy and safety profile of 3 mg cytisinicline administered TID for 12 weeks for vaping cessation.
Phase 2 • Sponsor: Achieve Life Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Tetris therapy for new moms: a game that could erase traumatic birth memories?
Symptom relief CompletedThis single-blind waitlist randomized controlled trial aims to investigate the efficacy of a single-session behavioral intervention composed of a brief evocation of the childbirth memory followed by a visuospatial task (the computer game "Tetris"), on childbirth-related intrusive…
Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New study tracks organ health after sickle cell 'Cures'
Knowledge-focused Recruiting nowSickle Cell Disease is one of the most common genetic diseases in the United States, occurring in approximately 1 in 400 births. Approximately 100,000 individuals are diagnosed with SCD in the United States. Mortality for children with SCD has decreased substantially over the pas…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
New device zaps spine tumor pain in clinical trial
Symptom relief CompletedThe SPARTA study (Spinery® Radiofrequency Ablation Device Study) is a prospective, multicenter, single-arm clinical investigation designed to evaluate the safety, performance, and efficacy of the Spinery® RF Generator and its sterile single-use accessories for the palliative trea…
Sponsor: Axon srl • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Brain zaps show promise for tough schizophrenia symptoms
Symptom relief CompletedThe major target of the study is to confirm the safety and efficacy of our augmented protocol of theta-burst TMS in schizophrenia. Our aim is to confirm the beneficial effects of rTMS treatment on multiple aspects of the disorder such as (1) clinical aspect in terms of PANSS, (2)…
Sponsor: Semmelweis University • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Could a silver gel halt cavities without the drill?
Disease control CompletedA single group observational study to determine the clinical response of dental caries lesions in primary teeth where 38% silver diamine fluoride gel is applied and cover with 2.5% sodium fluoride varnish. Additionally, to assess parent satisfaction with treatment with 38% silver…
Sponsor: Advantage Silver Dental Arrest, LLC • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New daily pill could ease ADHD symptoms in kids
Symptom relief CompletedThis trial will be conducted to evaluate the efficacy of centanafadine once daily (QD) extended release (XR) versus placebo in the treatment of child subjects (4 to 12 years, inclusive) with ADHD. The trial will consist of a screening period, a double-blind treatment period, and …
Phase 3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC